ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CDIO vs BMRA // EV/EBITDA & P/E VALUATION

Cardio Diagnostics Holdings Inc. (NASDAQ) VS. Biomerica Inc. (NASDAQ) • 15-METRIC TALLY: CDIO 1 — BMRA 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDIO VS. BMRA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CDIO BMRA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 8.10% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -57.50% -16.20% -41.30 BMRA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 41.0 37.0 +4.01 CDIO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $5.2M $8.0M -$2.8M BMRA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CDIO REV BMRA REV CDIO GROSS % BMRA GROSS % CDIO FCF BMRA FCF
FY 2025 $14.8K $4.5M — 8.1% -$5.9M -$3.4M
FY 2024 $34.9K $5.3M — 9.4% -$5.2M -$3.8M
FY 2023 $17.1K $5.4M — — -$5.7M -$5.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDIO // BETA —
BMRA // BETA —